AKR vs FCPT

The Advanced Deterministic Scorecard reveals significant concerns: a weak Piotroski F-Score of 4/9 indicates marginal financial health, and the absence of an Altman Z-Score prevents a full distress risk assessment. Despite a seemingly reasonable Price/Book of 1.17 and a dividend yield of 3.96%, the stock trades at extreme valuation multiples (P/E of 153.77, Forward P/E of 71.39) while exhibiting declining fundamentals—revenue and earnings are contracting YoY by 2.40% and 57.10%, respectively. Negative ROE of -1.67%, a dangerously high payout ratio of 607.69%, and inconsistent earnings beats (only 1 of last 4 quarters) further undermine confidence. Although analyst consensus recommends a 'buy', the technical trend is deeply bearish and insider sentiment is weak.

FCPT exhibits significant valuation misalignment, with a current price of $25.43 trading far above its Graham Number ($15.94) and Intrinsic Value ($8.61). While the Piotroski F-Score of 4/9 indicates stable financial health, the company's dividend profile is unsustainable with a payout ratio of 131.33%. Stagnant earnings growth (0.60% YoY) and a bearish technical trend (0/100) further undermine the bullish analyst consensus. The combination of overvaluation and poor liquidity (Current Ratio 0.48) suggests a high risk of price correction.